Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 91 Carcinoma, Non-Small-Cell Lung 53 Lung Neoplasms 22 Hodgkin Disease 15 Recurrence 11 Lymphoma 10 Neoplasm Metastasis 9 Prostatic Neoplasms 7 Triple Negative Breast Neoplasms 6 Neoplasms 6 Sarcoma 4 Rhabdomyosarcoma 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Large B-Cell, Diffuse 4 Adenocarcinoma of Lung 4 Multiple Myeloma 3 Mesothelioma, Malignant 3 Mesothelioma 3 Breast Neoplasms, Male 3 Uterine Cervical Neoplasms 2 Ovarian Neoplasms 2 Neuroblastoma 2 Melanoma 2 Lymphoma, Large-Cell, Anaplastic 2 HER2-negative Breast Cancer 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Colonic Neoplasms 2 Brain Neoplasms 2 Advanced Breast Cancer 2

Interventions

Temozolomide 7 Radiotherapy 3 Everolimus 3 nimotuzumab 2 Erlotinib Hydrochloride 2 Cyclophosphamide 2 Bevacizumab 2 tovorafenib 1 ribociclib 1 palbociclib 1 olutasidenib 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Vinorelbine 1 Valproic Acid 1 Topotecan 1 TIC10 compound 1 Radiation 1 Proto-Oncogene Proteins c-akt 1 Phosphatidylinositol 3-Kinases 1 Panobinostat 1 Lomustine 1 Irinotecan 1 Injections 1 GDC-0084 1 Etoposide 1 Drug Therapy 1 Doxorubicin 1 Diphtheria-Tetanus Vaccine 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Diffuse Intrinsic Pontine Glioma × Vinorelbine × Clear all

NCT03620032 2023-12-06

DIPG

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡